Where
Others Hesitate,
We Innovate.
ENDLESS POSSIBILITIESWITH AESARA
AT ISPOR EUROPE 2024
NOV 17-20
Posters
ISPOR EU 2024
Yeh D, Roeder C, Longo R, Chamoux C, Manuel F, Saito K
MSR55
ISPOR EU 2024
Bahar Nasim, Chamoux Catherine, Outteridge Gavin
HTA304
ISPOR EU 2024
Gyuenet Alexandra, Chamoux Catherine
HTA83
ISPOR EU 2024
Chamoux Catherine, Outteridge Gavin
HTA11
ISPOR EU 2024
Cost-Consequence Model Comparing the Originator r-hFSH-alfa and Its Biosimilar for ≤4 Complete Ovarian Stimulation Cycles During Assisted Reproductive Technology Treatment in Spain, France, and Germany
Claudia Roeder, Kemal Uca, Helene Vioix, Vivek Chaudhari, Cristina Masseria, Roberta Longo, Juan-Enrique Schwarze
EE39
ISPOR EU 2024
Is Universal Screening for Hypothyroidism in Pregnant Women a Cost-Effective Strategy in Indonesia and Mexico?
Aldo Ferreira, Dicky, L Tahapary, Gloria Angélica González Villaseñor, Mila Maidarti, Ulul Albab, Ketut Suastika, Juan-Omar Toledo, Andri Kusandri, Cristina Masseria, Roberta Longo, Claudia Roeder, Julian Dettenbach, José Gotes Palazuelos, Tjokorda Gde Dalem Pemayun
EE602
ISPOR EU 2024
Taxonomy of the Full Value of mRNA Influenza and COVID-19 Combination Vaccines
Jp Sevilla, Joseph Knee, Genevieve Meier, Jingyan Yang, Manuela Di Fusco, Tianyan Hu, David E. Bloom
HTA405
Panel Participation
Session Date & Time: Monday, Nov 18 | 5:00 - 6:00 PM GMT +1
Room 115, Level P1
Speakers:
– Fabrizio Gianfrate, PhD, MSc; Professor of Health Economics, University of Ferrara
– Cristina Masseria, MSc, PhD; Market Access and HEOR Strategic Leader, AESARA
– Francis Pang, MBA; Gene Therapy, Rare Disease Market Access & Health Economics Professional, Orchard Therapeutics
– Gergana Zlateva, BA, MPA, PhD; VP, Global Oncology Market Access Lead, Pfizer Inc.
Session Date & Time: Monday, Nov 18, 2024 | 5:00 - 6:00 PM GMT+1
Connection Zone, VIP Room
Speakers:
– Jens Grueger, PhD; Affiliate Professor, University of Washington
– Sissi V Pham, Pharm.D.; Chief Executive Officer, AESARA
– Laura Pizzi, PharmD, MPH; Chief Science Officer, ISPOR
– David Thompson, PhD; Founder & Principal Consultant, Rubidoux Research LLC
Session Date & Time: Tuesday, Nov 19, 2024 | 10:15–11:15 AM GMT+1
Room 112, Level P1
Speakers:
– Fang-Ju (Irene) Lin, PhD; Associate Professor, National Taiwan University
– David Shum, PharmD, MBA, MSc; Director, Strategic Access and Pricing, Hoffmann-La Roche Canada
– Anouchka Vidal, PharmD, MBA; Access Evidence Lead, F. Hoffmann-La Roche LTD
– Danny Yeh, PhD; Executive Director, AESARA
Session Date & Time: Tuesday, Nov 19, 2024 | 1:45–2:45 PM GMT+1
Room 211, Level P2
Speakers:
– Indranil Bagchi, PhD; Vice President, Value Evidence & Outcomes, GSK
– Patrick K. Hopkinson, BPharm, MBA, MSc; Managing Director, PHTA Consulting
– Cristina Masseria, MSc, PhD; Market Access and HEOR Strategic Leader, AESARA
– Brian O’Rourke, PhD; President 2023/24, ISPOR
AESARA UNI
Your leaning journey begins here!
At UNI, we believe that learning should be an adventure, tailored to your unique goals and aspirations. Our state-of-the-art e-learning modules provide a comprehensive and interactive platform that adapts to your needs, ensuring that your journey is both engaging and rewarding.
Tailored Learning Patha
Every learner is unique, and so are our modules. We offer a personalized learning experience that aligns with your specific goals and interests
Engaging and Interactive
Enjoy a rich variety of learning materials, including videos, interactive quizzes, and hands-on activities that make learning fun and effective
Achieve Your Goals
Gain the skills and knowledge you need to excel in your Value & Access or explore new areas of interest with confidence
Couldn't join us at ISPOR Europe?No worries 😉
Scan and Experience theENDLESS POSSIBILITIES
